VentureMed Group has announced new data presentations on the treatment of peripheral arterial disease (PAD) with drug-coated balloon (DCBs) in addition to 12-month AV Registry Data. These presentations will be given as part of the VEITH Symposium Annual Scientific Meeting 2022 (15–19 November, New York, USA).
Data presented will cover the use of FLEX Vessel Prep System in both PAD treatment with DCB and also in arteriovenous (AV) access interventions. The AV Access presentation will expand the six-month AV Registry data presented at VASA in June with 12-month results.
The first of two presentations will be titled “Late Breaking Trial with FLEX Vessel Prep and DCBs Show Better 12-Month Results With FemPop” and be presented by Eric A Secemsky (Beth Israel Deaconess Medical Centre, Boston, USA).
The second is titled “FLEX Vessel Prep System: Clinical Outcomes and Utility in HD Access Practice—AV Registry 12-Month Study Results,” and will be shared by primary investigator John E Aruny (Dialysis Access Institute, Orangeburg, USA).